The DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.
α-Synuclein pathology in Parkinson’s disease and related α-synucleinopathies
Open accessAbstract
Over 20 years ago, the synaptic protein alpha-synuclein was identified as the primary component of the Lewy bodies (LBs) that are a sine qua non of Parkinson’s disease (PD). Since that time, extensive research has demonstrated that alpha-synuclein pathology is not only a hallmark of PD, but can also cause neuronal dysfunction and death. Detailed staging of alpha-synuclein pathology in the brains of patients has revealed a progressive pattern of pathology that correlates with the symptoms of disease. Early in the disease course, PD patients exhibit motor dysfunction, and alpha-synuclein pathology at this stage is primarily found in regions controlling motor function. At later stages of disease as patients’ cognitive function deteriorates, alpha-synuclein pathology can be found in cortical structures responsible for higher cognitive processing. The stereotypical progression of alpha-synuclein pathology through the brain over time suggests that there may be a physical transmission of pathological alpha-synuclein from one area of the brain to another. The transmission hypothesis posits that an initial seed of pathological alpha-synuclein in one neuron may be released and taken up by another vulnerable neuron and thereby initiate pathological misfolding of alpha-synuclein in the recipient neuron. In recent years, convergent evidence from various studies has indicated that pathological protein transmission can occur in the human brain. Cell and animal models based on the transmission hypothesis have shown not only that pathological alpha-synuclein can be transmitted from cell-to-cell, but that this pathology can lead to neuronal dysfunction and degeneration. The alpha-synuclein transmission hypothesis has profound implications for treatment of what is currently an intractable neurodegenerative disease. In this review, we explore the evidence for cell-to-cell transmission of pathological alpha-synuclein, the current understanding of how pathological alpha-synuclein can move to a new cell and template misfolding, and the therapeutic implications of alpha-synuclein transmission.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
5 retracted
Masliah, E., Rockenstein, E., Mante, M., Crews, L., Spencer, B., Adame, A., Patrick, C., Trejo, M., Ubhi, K., Rohn, T. T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019338 · Cited by 423
RetractedSpencer, B. J., Valera, E., Rockenstein, E. M., Overk, C., Mante, M., Adame, A., Zago, W. M., Seubert, P. A., Barbour, R., Schenk, D., et al. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0410-8 · Cited by 91
RetractedEl‐Agnaf, O. M. A., Overk, C., Rockenstein, E. M., Mante, M., Florio, J. B., Adame, A., Vaikath, N. N., Majbour, N. K., Lee, S., Kim, C., et al. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.05.002 · Cited by 88
RetractedSpencer, B. J., Emadi, S., Desplats, P., Eleuteri, S., Michael, S. A., Kosberg, K. A., Shen, J., Rockenstein, E. M., Patrick, C., Adame, A., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.129 · Cited by 85
RetractedSpencer, B. J., Williams, S. M., Rockenstein, E. M., Valera, E., Xin, W., Mante, M., Florio, J. B., Adame, A., Masliah, E., & Sierks, M. R. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.321 · Cited by 45
RetractedStaging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Self-citationMutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Cited by
Upregulation of α-synuclein following immune activation: Possible trigger of Parkinson's disease
Kasen, A., Houck, C., Burmeister, A. R., Sha, Q., Brundin, L., & Brundin, P. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105654 · Cited by 78
Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer’s disease
Eteleeb, A. M., Novotny, B. C., Tarraga, C. S., Sohn, C., Dhungel, E., Brase, L., Nallapu, A., Buss, J., Farias, F., Bergmann, K., et al. (2024) · PLOS Biology · doi:10.1371/journal.pbio.3002607 · Cited by 64
Limegrover, C. S., Yurko, R., Izzo, N. J., LaBarbera, K. M., Rehak, C., Look, G., Rishton, G., Safferstein, H., & Catalano, S. M. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24782 · Cited by 43
Metadata
- Authors
- Henderson, M. X., Trojanowski, J. Q., & Lee, V. M.-Y.
- Venue
- Neuroscience Letters
- Publisher
- Elsevier BV
- Published
- 2019-09
- Volume
- 709
- Pages
- 134316
- ISSN
- 0304-3940 (ISSN-L)
- OpenAlex
- W2948657684
- Cited by
- 291
- References
- 158
- FWCI
- 18.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: α-Synuclein pathology in Parkinson’s disease and related α-synucleinopathies. https://app.cochat.ai/papers/10.1016/j.neulet.2019.134316
- The paper
- Henderson, M. X., Trojanowski, J. Q., & Lee, V. M.-Y. (2019). α-Synuclein pathology in Parkinson’s disease and related α-synucleinopathies. Neuroscience Letters. https://doi.org/10.1016/j.neulet.2019.134316
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.